BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 11158295)

  • 1. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
    Cloutier JF; Veillette A
    EMBO J; 1996 Sep; 15(18):4909-18. PubMed ID: 8890164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
    Cloutier JF; Veillette A
    J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
    Davidson D; Cloutier JF; Gregorieff A; Veillette A
    J Biol Chem; 1997 Sep; 272(37):23455-62. PubMed ID: 9287362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders.
    Veillette A; Rhee I; Souza CM; Davidson D
    Immunol Rev; 2009 Mar; 228(1):312-24. PubMed ID: 19290936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition.
    Garton AJ; Burnham MR; Bouton AH; Tonks NK
    Oncogene; 1997 Aug; 15(8):877-85. PubMed ID: 9285683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins.
    Yang G; Li Q; Ren S; Lu X; Fang L; Zhou W; Zhang F; Xu F; Zhang Z; Zeng R; Lottspeich F; Chen Z
    Proteomics; 2009 Nov; 9(21):4944-61. PubMed ID: 19743411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
    Sayós J; Martínez-Barriocanal A; Kitzig F; Bellón T; López-Botet M
    Biochem Biophys Res Commun; 2004 Nov; 324(2):640-7. PubMed ID: 15474475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of ZO-1/2 as a novel scaffold for Src/Csk regulatory circuit.
    Saito K; Enya K; Oneyama C; Hikita T; Okada M
    Biochem Biophys Res Commun; 2008 Feb; 366(4):969-75. PubMed ID: 18086565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk.
    Kuo SS; Moran P; Gripp J; Armanini M; Phillips HS; Goddard A; Caras IW
    J Neurosci Res; 1994 Aug; 38(6):705-15. PubMed ID: 7807586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.